Interleukin 37 expression protects mice from colitis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 40, 2011, Pages 16711-16716

  McNamee, Eóin N ^a,c,d   Masterson, Joanne C ^a,b   Jedlicka, Paul ^c,d   McManus, Martine ^c,d   Grenz, Almut ^a,c,d   Collins, Colm B ^a,b   Nold, Marcel F ^d   Nold Petry, Claudia ^d   Bufler, Philip ^e   Dinarello, Charles A ^d   Rivera Nieves, Jesús ^f  

^a Mucosal Inflammation Program   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; Inflammatory bowel disease; Intestine

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 37; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; COLITIS; COLON MUCOSA; CONTROLLED STUDY; HEMATOPOIETIC CELL; HISTOPATHOLOGY; LAMINA PROPRIA; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENE;

ANALYSIS OF VARIANCE; ANIMALS; COLITIS; DEXTRAN SULFATE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; MICE; MICE, TRANSGENIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS;

EID: 80053624991     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111982108     Document Type: Article

References (30)

1. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521-533. (Pubitemid 37328672)
2. Targan SR, et al.; Crohn's Disease cA2 Study Group (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med 337:1029-1035.
3. Hanauer SB, et al.; ACCENT I Study Group (2002) Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 359:1541-1549. (Pubitemid 34621118)
4. Ito H, et al. (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126:989-996, discussion 947.
5. Sands BE, et al. (1999) Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology 117: 58-64. (Pubitemid 29297620)
6. Fedorak RN, et al.; The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group (2000) Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. Gastroenterology 119:1473-1482. (Pubitemid 32198672)
7. Babyatsky MW, Rossiter G, Podolsky DK (1996) Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology 110:975-984. (Pubitemid 26113734)
8. Casini-Raggi V, et al. (1995) Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154:2434-2440.
9. Dinarello C, et al. (2010) IL-1 family nomenclature. Nat Immunol 11:973.
10. Kumar S, et al. (2000) Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 275:10308-10314. (Pubitemid 30202089)
11. Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE (2002) Genomic organization of the interleukin-1 locus. Genomics 79:726-733. (Pubitemid 34499489)
12. Smith VP, Alcami A (2000) Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J Virol 74:8460-8471. (Pubitemid 30666696)
13. Busfield SJ, et al. (2000) Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 66:213-216. (Pubitemid 30429756)
14. Kumar S, et al. (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine 18:61-71. (Pubitemid 34754095)
15. Pan G, et al. (2001) IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 13:1-7. (Pubitemid 32579216)
16. Bufler P, et al. (2002) A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 99:13723-13728. (Pubitemid 35215448)
17. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503-510. (Pubitemid 38969696)
18. Sharma S, et al. (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477-5482.
19. Nold MF, et al. (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014-1022.
20. Blumberg RS, Saubermann LJ, Strober W (1999) Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11:648-656.
21. Rubtsov YP, Rudensky AY (2007) TGFβ signalling in control of T-cell-mediated selfreactivity. Nat Rev Immunol 7:443-453. (Pubitemid 46834850)
22. Khalil PN, et al. (2007) Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 132:944-954. (Pubitemid 46440862)
23. Sikorski EE, Hallmann R, Berg EL, Butcher EC (1993) The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-α and IL-1. J Immunol 151:5239-5250. (Pubitemid 23332333)
24. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
25. Barbara G, Xing Z, Hogaboam CM, Gauldie J, Collins SM (2000) Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 46:344-349. (Pubitemid 30313385)
26. Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495-549. (Pubitemid 34293433)
27. Fiocchi C (2001) TGF-β/Smad signaling defects in inflammatory bowel disease: Mechanisms and possible novel therapies for chronic inflammation. J Clin Invest 108: 523-526.
28. Smith P, et al. (2007) Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178:4557-4566. (Pubitemid 46492408)
29. Siegmund B, Lehr HA, Fantuzzi G, Dinarello CA (2001) IL-1 β-converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci USA 98:13249-13254. (Pubitemid 33051348)
30. McNamee EN, et al. (2010) Novel model of TH2-polarized chronic ileitis: The SAMP1 mouse. Inflamm Bowel Dis 16:743-752.